Suppr超能文献

暴露前预防的知晓率与覆盖率:2022年南非产前HIV哨点调查结果

PrEP Awareness and Coverage: Results from the 2022 South Africa Antenatal HIV Sentinel Survey.

作者信息

Shangase Nosipho, Kufa Tendesayi, Cheyip Mireille, Puren Adrian

机构信息

Centre for HIV and STI, National Institute for Communicable Diseases, Modderfontein Road Sandringham, Johannesburg, 2192, South Africa.

School of Public Health, University of the Witwatersrand, Johannesburg, South Africa.

出版信息

AIDS Behav. 2025 May;29(5):1692-1703. doi: 10.1007/s10461-024-04609-3. Epub 2025 Feb 13.

Abstract

Pregnant women have a high HIV incidence in South Africa (SA), increasing the risk of mother-to-child transmission (MTCT) of HIV. Strengthening coverage of HIV prevention strategies such as pre-exposure prophylaxis (PrEP) is essential to ending the epidemic in SA. We estimated awareness and coverage of PrEP among pregnant women attending antenatal clinics. Using the national cross-sectional antenatal HIV sentinel survey SA, that was conducted from February to April 2022, we performed descriptive and survey logistic regression analyses. Women were deemed as aware about PrEP if they reported ever having heard of PrEP. Women were eligible for PrEP if they were HIV-negative and had either: (1) an HIV-positive/status-unknown partner; (2) multiple sexual partners in the past twelve months; (3) a sexually transmitted infection in the preceding six months; or (4) sex under the influence of alcohol/drugs in the past six months. 31.18% (n = 7 271) of HIV-negative women were eligible for PrEP. Among eligible women, 33.65% (n = 2 403) were aware about PrEP, 3.58% (n = 271) took PrEP before pregnancy, and 6.50% (n = 507) were currently on PrEP. Compared to follow-up visit attendees, first ANC visit attendees were less likely to be: (1) aware about PrEP (adjusted odds ratio (aOR) = 0.65; 95% confidence interval (CI): 0.59-0.72), and (2) to currently be on PrEP (aOR = 0.69; 95% CI: 0.57-0.84). Women who had never tested for HIV before pregnancy were less likely to: (1) be aware about PrEP (aOR = 0.51; 95% CI: 0.45-0.59), and (2) currently be on PrEP (aOR = 0.56; 95% CI: 0.43-0.74) compared to those who had tested for HIV before pregnancy. Women who reported having an HIV-positive partner compared to those with an HIV-negative partner had higher: (1) PrEP awareness (aOR = 2.21; 95% CI: 1.80-2.71), and (2) PrEP coverage during pregnancy (aOR = 8.51; 95% CI: 6.43-11.25). Overall PrEP awareness and coverage were low. PrEP is being integrated into safe conception programs as an HIV prevention strategy. Entry into ANC presents an important opportunity to prevent new HIV infections among new mothers, accelerating the elimination of MTCT of HIV in the country.

摘要

在南非,孕妇的艾滋病毒感染率很高,这增加了母婴传播艾滋病毒的风险。加强暴露前预防(PrEP)等艾滋病毒预防策略的覆盖范围对于在南非终结该流行病至关重要。我们估计了在产前诊所就诊的孕妇中PrEP的知晓率和覆盖率。利用2022年2月至4月进行的南非全国横断面产前艾滋病毒哨点调查,我们进行了描述性和调查逻辑回归分析。如果女性报告曾听说过PrEP,则被视为知晓PrEP。如果女性艾滋病毒检测呈阴性且符合以下任一条件,则有资格使用PrEP:(1)有艾滋病毒呈阳性/状况不明的伴侣;(2)在过去十二个月内有多个性伴侣;(3)在过去六个月内感染过性传播感染;或(4)在过去六个月内有在酒精/药物影响下的性行为。31.18%(n = 7271)的艾滋病毒阴性女性有资格使用PrEP。在符合条件的女性中,33.65%(n = 2403)知晓PrEP,3.58%(n = 271)在怀孕前服用过PrEP,6.50%(n = 507)目前正在服用PrEP。与随访就诊者相比,首次产前检查就诊者不太可能:(1)知晓PrEP(调整优势比(aOR)= 0.65;95%置信区间(CI):0.59 - 0.72),以及(2)目前正在服用PrEP(aOR = 0.69;95% CI:0.57 - 0.84)。与怀孕前曾检测过艾滋病毒的女性相比,怀孕前从未检测过艾滋病毒的女性不太可能:(1)知晓PrEP(aOR = 0.51;95% CI:0.45 - 0.59),以及(2)目前正在服用PrEP(aOR = 0.56;95% CI:0.43 - 0.74)。与艾滋病毒阴性伴侣的女性相比,报告有艾滋病毒阳性伴侣的女性有更高的:(1)PrEP知晓率(aOR = 2.21;95% CI:1.80 - 2.71),以及(2)孕期PrEP覆盖率(aOR = 8.51;95% CI:6.43 - 11.25)。总体而言,PrEP的知晓率和覆盖率较低。PrEP正在作为一种艾滋病毒预防策略纳入安全受孕计划。进入产前检查为预防新妈妈感染新的艾滋病毒提供了一个重要机会,加速该国消除母婴传播艾滋病毒的目标。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验